Caps are often sold as cost control.
On the surface, this cost control sounds like the responsible and disciplined choice.
Lower reimbursement. Limit recovery. Restrict upside. Present it as reform. Promise premiums will fall and the system will stabilize.
In reality, however, this is neither the responsible nor disciplined choice.
Caps eliminate options, not cost. When you eliminate options in healthcare and personal injury, cost does not vanish. It just shifts over to those least equipped to carry it.
The Illusion of Cost Control
In recent legislative cycles, two things are happening regarding cap recoveries. One, they are more often tied to medical care provided on lien. Two, alternative reimbursement benchmarks are being introduced into court proceedings. The theory? It’s straightforward: if juries are exposed to lower payment rates like Medicare or negotiated commercial reimbursements, awards will come down. If awards come down, premiums will follow.
Well, that’s the promise.
The problem? This analysis treats healthcare like a static spreadsheet. It ignores how providers actually operate.
When a doctor treats a patient on lien, 30-day payment isn’t guaranteed. There is no automatic reimbursement from a commercial carrier. Say goodbye to certainty.
Say hello to risk, duration, administrative cost, and the very real possibility of nonpayment.
Capping recovery while ignoring those variables does not reduce the underlying cost of care. It simply reduces incentive to provide it.
Bill Charges Are Not Fantasy Numbers
One of the most persistent narratives in tort reform debates is the idea of “phantom damages” — the suggestion that the difference between a provider’s bill charge and a negotiated commercial reimbursement is somehow fictitious.
That’s a lie.
The bill charge is the amount the patient is legally responsible for. The starting point.
If someone has paid healthcare premiums for twenty years, they have effectively prepaid for access to negotiated rates. Those negotiated discounts are the result of long-term participation in an insurance system. They are not gifts from carriers. They are earned through decades of premium payments.
When a patient without that structure receives care on lien, the provider then enters into a different risk model. The timeline is extended, the collection risk increases, and the administrative burden expands. Payment, if it occurs, may come years later.
Discounting that bill to a rate designed for 30-day commercial reimbursement ignores duration and risk entirely.
Phantom damage? In that equation, it doesn’t exist. There’s a misunderstanding of how markets price risk.
What Happens When You Cap Recovery
Let’s be clear about incentives.
If reimbursements are compressed to levels that do not reflect risk and duration, rational providers will respond rationally.
They will reduce exposure. They will limit how many lien patients they see. And some will exit the space entirely.
This is not a moral failure. It is economic reality.
Healthcare practices operate with payroll, rent, malpractice coverage, equipment costs, and staff. They are not abstract public utilities. They are businesses with fixed and variable expenses.
When legislation introduces caps that ignore those realities, access shrinks. Providers simply cannot subsidize unlimited risk.
The cost then shifts.
Patients delay care or they settle early for less than their case is worth because they cannot afford to wait. Maybe they fall behind on rent and bills. Or they move into already strained government-funded systems.
The cost did not disappear. It moved.
The Market Already Prices for Risk
Critics often frame lien-based care as inflated or opportunistic. The opposite is usually true.
Markets with more participants become more efficient. Capital flows in. Returns normalize. Competition increases transparency. Pricing stabilizes.
When you artificially cap one side of the market, you do not create efficiency. You distort it. Third-party liability carriers continue to operate with profit motives. Commercial insurers negotiate aggressively. Capital participates across industries without controversy.
But when capital or structured servicing supports injured individuals and healthcare providers, suddenly it is treated as suspect.
That inconsistency matters.
If you want a more efficient system, you invite more disciplined participants on both sides of the street. You do not declare one side illegitimate and attempt to legislate away its economic viability.
Why Independence Matters
As these reforms move forward, one principle becomes increasingly important: independence. When reimbursements become discoverable, when funding structures are scrutinized, when juries are exposed to simplified averages, providers should not attempt to manage this complexity on their own.
Everything is discoverable. Every communication can be examined. Every inconsistency can be weaponized.
An independent servicing structure removes perceived conflicts, standardizes documentation and maximizes recoveries within the boundaries of the law. It allows physicians to focus on medical care while professionals manage the receivables respectfully and compliantly.
That independence is essential in a capped environment.
The Average Is Not Neutral
There is another development we expect to see.
As multiple reimbursement benchmarks are introduced into evidence, juries and mediators will often default to a simple average. Rather than selecting one rate or another, they will split the difference.
On its face, that feels balanced. In practice, it can be blunt.
An average of physician charge master rates, historic reimbursements, commercial contracts, and government programs does not necessarily reflect the true economic model of lien-based care. It reflects simplicity.
We have analyzed these potential scenarios across a wide range of providers. We believe there will still be premium reimbursement relative to government payor sources. It may not match historical levels, but it remains meaningful when structured correctly and serviced independently.
The key is preparation.
Hope is not a strategy. Modeling is.
The Moral and Financial Equation
Nearly three million Georgians rely on access to quality care following injury. Similar dynamics exist in other states considering comparable legislation.
Seeing patients on lien is not a loophole. It’s a bridge. It allows individuals without immediate liquidity to receive medically necessary treatment. It allows providers to be compensated for taking risk. It keeps care in the private market versus pushing it into already burdened public systems.
Caps that ignore this ecosystem do not improve it. They narrow it.
Don’t eliminate options. Clarify definitions, preserve access, and allow markets to function with transparency and discipline.
Cost control that sacrifices access is not reform. It’s just rationing by another name.
If we want a system that works for patients, providers, and responsible capital alike, we need guardrails that reflect economic reality, not blunt instruments that flatten it.
Caps feel decisive. Options sustain care. And once options disappear, rebuilding them is far more expensive than preserving them in the first place.